Home
>
National Drug Code (NDC)
>
MENOMUNE - A/C/Y/W-135 COMBINED
MENOMUNE - A/C/Y/W-135 COMBINED - 49281-489-01 - (NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN)
Drug Information of MENOMUNE - A/C/Y/W-135 COMBINED
| Product NDC: | 49281-489 |
| Proprietary Name: | MENOMUNE - A/C/Y/W-135 COMBINED |
| Non Proprietary Name: | NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN |
| Active Ingredient(s): | & nbsp; NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MENOMUNE - A/C/Y/W-135 COMBINED
| Product NDC: | 49281-489 |
| Labeler Name: | Sanofi Pasteur Inc. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA103924 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19811123 |
Package Information of MENOMUNE - A/C/Y/W-135 COMBINED
| Package NDC: | 49281-489-01 |
| Package Description: | 1 KIT in 1 PACKAGE (49281-489-01) * .5 mL in 1 VIAL * .6 mL in 1 VIAL |
NDC Information of MENOMUNE - A/C/Y/W-135 COMBINED
| NDC Code | 49281-489-01 |
| Proprietary Name | MENOMUNE - A/C/Y/W-135 COMBINED |
| Package Description | 1 KIT in 1 PACKAGE (49281-489-01) * .5 mL in 1 VIAL * .6 mL in 1 VIAL |
| Product NDC | 49281-489 |
| Product Type Name | VACCINE |
| Non Proprietary Name | NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19811123 |
| Marketing Category Name | BLA |
| Labeler Name | Sanofi Pasteur Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
